Freenome

11 articles with Freenome

• Freenome’s IMPACT Advisory Board Brings Strategic Insight and Real-World Experience to AI-Genomics Cancer Tests

  7/12/2018

  Freenome announced the creation of its IMPACT Advisory Board, a group tasked with helping Freenome’s leadership team optimize the company’s short- and long-term strategies, including those for its first commercial launch.

• 

  Top 10 Stories of the First Half of 2018

  7/6/2018

  It’s hard to believe 2018 is half over. There have been plenty of interesting and important stories in the biopharma space this year. Here’s a look at our top 10 stories so far, counting down from 10 to the number one story.

• QIAGEN showcases innovation in NGS solutions for precision medicine at ASCO 2018

  5/31/2018

  QIAGEN N.V. announced a partnership with Freenome, a leading artificial intelligence (AI) genomics company, to accelerate the development and commercialization of next-generation sequencing (NGS) tests to enable precision medicine in cancer treatment.

• Freenome and Biognosys Announce Collaboration to Improve Early-Cancer Detection and Treatment

  4/24/2018

  Freenome’s platform is poised to detect cancer at its earliest stages and help clinicians optimize the next generation of precision therapies.

• 

  What You Need to Know About Freenome

  1/8/2018

  Freenome, headquartered in South San Francisco, is focused on developing a diagnostic test for early detection of cancer and other diseases on the so-called "liquid biopsy," in other words, blood.
• 

  Top 20 Life Science Startups to Watch in 2018

  1/2/2018

  BioSpace is proud to present its NextGen "Class of 2018," a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.

• Invitae Chairman Randy Scott Joins Freenome Board of Directors

  12/21/2017

  For nearly three decades, Dr. Scott has been an entrepreneur and visionary leader in genomic medicine.

• Freenome Announces Formation of Scientific Advisory Board

  10/19/2017

  Freenome announced the formation of its Scientific Advisory Board (SAB) comprised of leading experts in genomics and machine learning.

• Freenome Announces Series A Extension Led By Section 32

  8/28/2017

• Freenome Appoints Abraham Tzou, M.D. Vice President, Regulatory Affairs

  8/3/2017

• 28-Year Old's Bay Area Startup Freenome Just Landed $65 Million

  3/1/2017